Cleared Traditional

K110390 - ETG 255 COMBO STIMUALTOR, TEN 260 STIMUALTOR

K110390 is an FDA 510(k) clearance for ETG 255 COMBO STIMUALTOR, manufactured by Handelshaus Dittman GmbH. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 168-day FDA review.

K110390 · Handelshaus Dittman GmbH · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2011
Decision
168d
Days
Class 2
Risk

K110390 is an FDA 510(k) clearance for the ETG 255 COMBO STIMUALTOR, TEN 260 STIMUALTOR. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Handelshaus Dittman GmbH (Shenzhen, CN). The FDA issued a Cleared decision on July 29, 2011 after a review of 168 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Handelshaus Dittman GmbH devices

FDA 510(k) Submission Details - K110390

510(k) Number K110390 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 11, 2011
Decision Date July 29, 2011
Days to Decision 168 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 148d · This submission: 168d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 175
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K110390.
SENSUS
K121184 · Neurometrix, Inc. · Aug 2012
NEUROTECH PLUS
K112258 · Bio-Medical Research, Ltd. · Jan 2012
KNEEHAB XP
K110350 · Bio-Medical Research, Ltd. · Aug 2011
4 CHANNELS MULTIPLE MODEL DIGITAL ELECTRICAL STIMULATOR, MODEL NUVOSTIM IV, WL-2504A
K100399 · Well-Life Healthcare Limited · Jun 2010
HIVOX ELECTRIC STIMULATOR TENS & EMS, HD2
K092448 · Hivox Biotek, Inc. · Mar 2010
LUMBOFIX CONDUCTIVE GARMENT, MODEL 420 BACK
K091317 · Bio-Medical Research, Ltd. · Jun 2009